T1	Participants 105 120	type 2 diabetes
T2	Participants 308 408	patients with type 2 diabetes (T2D) and inadequate glycaemic control on a sub-maximal metformin dose
T3	Participants 475 536	metformin-tolerant patients with T2D on metformin monotherapy
T4	Participants 1202 1225	A total of 286 patients
T5	Participants 2012 2111	metformin-tolerant patients with T2D (inadequately controlled on sub-maximal metformin monotherapy)
